Mouse models for breast cancer metastasis

Biochemical and Biophysical Research Communications

Volumn 394, Issue 3, 2010, Pages 443-447

  Kim, Ik Soo ^a   Baek, Sung Hee ^a  

^a Seoul National University   (South Korea)

Author keywords

Breast cancer; Imaging; Metastasis; Mouse model

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; BIOINFORMATICS; BREAST CANCER; CANCER RELAPSE; CANCER TRANSPLANTATION; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; TUMOR GROWTH;

ANIMALS; BREAST NEOPLASMS; DISEASE MODELS, ANIMAL; FEMALE; GENETIC ENGINEERING; HUMANS; MICE; MICE, TRANSGENIC; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION;

ANIMALIA;

EID: 77950518404     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.03.070     Document Type: Short Survey

References (55)

1. Weigelt B., Peterse J.L., and van't Veer L.J. Breast cancer metastasis: markers and models. Nat. Rev. Cancer 5 (2005) 591-602
2. Iiizumi M., Liu W., Pai S.K., et al. Drug development against metastasis-related genes and their pathways: a rationale for cancer therapy. Biochim. Biophys. Acta - Rev. Cancer 1786 (2008) 87-104
3. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
4. Eccles S.A., and Welch D.R. Metastasis: recent discoveries and novel treatment strategies. Lancet 369 (2007) 1742-1757
5. Vernon A., Bakewell S., and Chodosh L. Deciphering the molecular basis of breast cancer metastasis with mouse models. Rev. Endocr. Metab. Disord. 8 (2007) 199-213
6. Ursini-Siegel J., Schade B., Cardiff R.D., et al. Insights from transgenic mouse models of ERBB2-induced breast cancer. Nat. Rev. Cancer 7 (2007) 389-397
7. Thyagarajan T., Totey S., Danton M.J.S., et al. Genetically altered mouse models: the good, the bad, and the ugly. Crit. Rev. Oral Biol. Med. 14 (2003) 154-174
8. J. Rivera, L. Tessarollo, Genetic background and the dilemma of translating mouse studies to humans, Immunity 28 (2008) 1-4.
9. Radiloff D.R., Rinella E.S., and Threadgill D.W. Modeling cancer patient populations in mice: complex genetic and environmental factors. Drug Discov. Today Dis. Models 4 (2007) 83-88
10. Han H.-J., Russo J., Kohwi Y., et al. SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis. Nature 452 (2008) 187-193
11. Karnoub A.E., Dash A.B., Vo A.P., et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449 (2007) 557-563
12. Muller A., Homey B., Soto H., et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 410 (2001) 50-56
13. Chabottaux V., Ricaud S.H., Host L., et al. Membrane-Type 4 Matrix Metalloproteinase (MT4-MMP) induces lung metastasis by alteration of primary breast tumor vascular architecture. J. Cell. Mol. Med. 13 (2009) 4002-4013
14. Bos P.D., Zhang X.H.F., Nadal C., et al. Genes that mediate breast cancer metastasis to the brain. Nature 459 (2009) 1005-1009
15. Nguyen D.X., Bos P.D., and Massague J. Metastasis: from dissemination to organ-specific colonization. Nat. Rev. Cancer 9 (2009) 274-284
16. Hoenerhoff M.J., Chu I., Barkan D., et al. BMI1 cooperates with H-RAS to induce an aggressive breast cancer phenotype with brain metastases. Oncogene 28 (2009) 3022-3032
17. Minn A.J., Gupta G.P., Siegel P.M., et al. Genes that mediate breast cancer metastasis to lung. Nature 436 (2005) 518-524
18. Kaplan R.N., Riba R.D., Zacharoulis S., et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438 (2005) 820-827
19. Kuperwasser C., Dessain S., Bierbaum B.E., et al. A mouse model of human breast cancer metastasis to human bone. Cancer Res. 65 (2005) 6130-6138
20. Jonkers J., and Derksen P. Modeling metastatic breast cancer in mice. J. Mammary Gland Biol. Neoplasia 12 (2007) 191-203
21. Maglione J.E., Moghanaki D., Young L.J.T., et al. Transgenic polyoma middle-T mice model premalignant mammary disease. Cancer Res. 61 (2001) 8298-8305
22. Blackburn A., and Jerry D.J. Knockout and transgenic mice of Trp53: what have we learned about p53 in breast cancer?. Breast Cancer Res. 4 (2002) 101-111
23. Yumei Y., Ting Hu Q., Claudine K., et al. Molecular mechanisms of breast cancer progression: lessons from mouse mammary cancer models and gene expression profiling. Breast Dis. 19 (2004) 69-82
24. Julien S.G., Dube N., Read M., et al. Protein tyrosine phosphatase 1B deficiency or inhibition delays ErbB2-induced mammary tumorigenesis and protects from lung metastasis. Nat. Genet. 39 (2007) 338-346
25. Maroulakou I.G., Oemler W., Naber S.P., et al. Akt1 ablation inhibits, whereas Akt2 ablation accelerates, the development of mammary adenocarcinomas in mouse mammary tumor virus (MMTV)-ErbB2/neu and MMTV-polyoma middle T transgenic mice. Cancer Res. 67 (2007) 167-177
26. Lopez J.I., Camenisch T.D., Stevens M.V., et al. CD44 attenuates metastatic invasion during breast cancer progression. Cancer Res. 65 (2005) 6755-6763
27. Lin E.Y., Nguyen A.V., Russell R.G., et al. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J. Exp. Med. 193 (2001) 727-740
28. + T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell 16 (2009) 91-102
29. Joyce J.A., and Pollard J.W. Microenvironmental regulation of metastasis. Nat. Rev. Cancer 9 (2009) 239-252
30. Lin S.-C.J., Lee K.-F., Nikitin A.Y., et al. Somatic mutation of p53 leads to estrogen receptor {alpha}-positive and -negative mouse mammary tumors with high frequency of metastasis. Cancer Res. 64 (2004) 3525-3532
31. Sharpless N.E., and DePinho R.A. The mighty mouse: genetically engineered mouse models in cancer drug development. Nat. Rev. Drug Discov. 5 (2006) 741-754
32. Kouros-Mehr H., Bechis S.K., Slorach E.M., et al. GATA-3 links tumor differentiation and dissemination in a luminal breast cancer model. Cancer Cell 13 (2008) 141-152
33. D'Cruz C.M., Gunther E.J., Boxer R.B., et al. c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations. Nat. Med. 7 (2001) 235-239
34. Green J.E., and Hudson T. The promise of genetically engineered mice for cancer prevention studies. Nat. Rev. Cancer 5 (2005) 184-198
35. Artandi S.E., Chang S., Lee S.-L., et al. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 406 (2000) 641-645
36. Ahmed F., Wyckoff J., Lin E.Y., et al. GFP expression in the mammary gland for imaging of mammary tumor cells in transgenic mice. Cancer Res. 62 (2002) 7166-7169
37. Egeblad M., Ewald A.J., Askautrud H.A., et al. Visualizing stromal cell dynamics in different tumor microenvironments by spinning disk confocal microscopy. Dis. Models Mech. 1 (2008) 155-167
38. Wyckoff J.B., Wang Y., Lin E.Y., et al. Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. Cancer Res. 67 (2007) 2649-2656
39. Wyckoff J.B., Jones J.G., Condeelis J.S., et al. A critical step in metastasis: in vivo analysis of intravasation at the primary tumor. Cancer Res. 60 (2000) 2504-2511
40. Condeelis J., and Segall J.E. Intravital imaging of cell movement in tumours. Nat. Rev. Cancer 3 (2003) 921-930
41. van't Veer L.J., Dai H., van de Vijver M.J., et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415 (2002) 530-536
42. van de Vijver M.J., He Y.D., van't Veer L.J., et al. A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med. 347 (2002) 1999-2009
43. Kang Y., Siegel P.M., Shu W., et al. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3 (2003) 537-549
44. Ojalvo L.S., King W., Cox D., et al. High-density gene expression analysis of tumor-associated macrophages from mouse mammary tumors. Am. J. Pathol. 174 (2009) 1048-1064
45. Qi Q., Gu H., Yang Y., et al. Involvement of matrix metalloproteinase 2 and 9 in gambogic acid induced suppression of MDA-MB-435 human breast carcinoma cell lung metastasis. J. Mol. Med. 86 (2008) 1367-1377
46. Charafe-Jauffret E., Ginestier C., Iovino F., et al. Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. Cancer Res. 69 (2009) 1302-1313
47. Lu X., Wang Q., Hu G., et al. ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis. Genes Dev. 23 (2009) 1882-1894
48. Harrell J.C., Dye W.W., Allred D.C., et al. Estrogen receptor positive breast cancer metastasis: altered hormonal sensitivity and tumor aggressiveness in lymphatic vessels and lymph nodes. Cancer Res. 66 (2006) 9308-9315
49. Lacroix M., and Leclercq G. Relevance of breast cancer cell lines as models for breast tumours: an update. Breast Cancer Res. Treat. 83 (2004) 249-289
50. Neve R.M., Chin K., Fridlyand J., et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10 (2006) 515-527
51. Bouchard L., Lamarre L., Tremblay P.J., et al. Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogene. Cell 57 (1989) 931-936
52. Siegel P.M., Dankort D.L., Hardy W.R., et al. Novel activating mutations in the neu proto-oncogene involved in induction of mammary tumors. Mol. Cell. Biol. 14 (1994) 7068-7077
53. Li B., Rosen J.M., McMenamin-Balano J., et al. Neu/ERBB2 cooperates with p53-172H during mammary tumorigenesis in transgenic mice. Mol. Cell. Biol. 17 (1997) 3155-3163
54. Brodie S.G., Xu X.L., Qiao W.H., et al. Multiple genetic changes are associated with mammary tumorigenesis in Brca1 conditional knockout mice. Oncogene 20 (2001) 7514-7523
55. Moody S.E., Sarkisian C.J., Hahn K.T., et al. Conditional activation of neu in the mammary epithelium of transgenic mice results in reversible pulmonary metastasis. Cancer Cell 2 (2002) 451-461